← Browse by Condition
Medical Condition

asthma

Total Trials
22
Recruiting Now
22
Trial Phases
Phase 3, Phase 4

Asthma clinical trials are increasingly stratified by phenotype β€” Type 2 high (eosinophilic, IgE-mediated) versus Type 2 low (neutrophilic or paucigranulocytic) β€” because this distinction predicts response to biologic therapies. The anti-IL-5, anti-IL-4/13, and anti-TSLP antibody classes have revolutionized severe asthma management, and trials now aim to achieve full remission rather than just symptom control.

Trials evaluate dupilumab combinations, tezepelumab (anti-TSLP) in Type 2 low asthma, itepekimab, biologic step-down strategies, and oral corticosteroid-sparing approaches. Digital inhalers with adherence monitoring are being validated as outcomes tools. Bronchial thermoplasty for severe non-biologic-responsive patients remains an active surgical comparator.

Frequently Asked Questions — asthma Clinical Trials

How many clinical trials are currently recruiting for asthma?
ClinicalMetric currently tracks 22 actively recruiting clinical trials for asthma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 22. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for asthma?
asthma research spans Phase 3 (5 trials), Phase 4 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a asthma clinical trial?
Eligibility criteria for asthma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
5
Phase 4
2
Top Sponsors
GlaxoSmithKline 3 trials
AstraZeneca 1 trial
Nantes University Hospital 1 trial
Kavita Parikh 1 trial
Cairo University 1 trial

Recruiting Clinical Trials

NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Enrollment
440 pts
Location
United States, China...
Sponsor
AstraZeneca
View Trial →
NCT05525169
Recruiting
Study of the Impact of Exposure to Outdoor and Indoor Pollutants in Patients With Asthma
Enrollment
30 pts
Location
France
Sponsor
Nantes University Hospital
View Trial →
NCT05991115
Recruiting
Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care
Enrollment
340 pts
Location
United States
Sponsor
Kavita Parikh
View Trial →
NCT07446985
Recruiting
Is There a Benefit From Addition of Physical Exercise to Diet Restriction/Limitation in PCOS Women With Asthma?
Enrollment
40 pts
Location
Egypt
Sponsor
Cairo University
View Trial →
NCT06524856
Recruiting
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
Enrollment
20 pts
Location
United States
Sponsor
University of Nebraska
View Trial →
NCT07037511
Recruiting
Effects of Salbutamol in Athletes and Implications for Screening and Sports
Enrollment
64 pts
Location
Canada
Sponsor
University of British Columbia
View Trial →
NCT07645248 Phase 3
Recruiting
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
Enrollment
110 pts
Location
United States, Argen...
Sponsor
GlaxoSmithKline
View Trial →
NCT07136025
Recruiting
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
Enrollment
200 pts
Location
China
Sponsor
Beijing Chao Yang Hospital
View Trial →
NCT06570889 Phase 3
Recruiting
VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
Enrollment
2,000 pts
Location
Denmark
Sponsor
Professor Klaus Bønnelykke
View Trial →
NCT07228052 Phase 4
Recruiting
Giving Asthmatics Intramuscular Steroids for Preventing Return to the Emergency Department
Enrollment
182 pts
Location
United States
Sponsor
Montefiore Medical Center
View Trial →
NCT06286085
Recruiting
A Comparison of Diagnostic Testing Modalities in the Assessment of Asthma
Enrollment
2,000 pts
Location
United Kingdom
Sponsor
Portsmouth Hospitals NHS Trust
View Trial →
NCT07289789
Recruiting
Comparative Effects of Buteyko Versus Pilates Breathing Combined With McKenzie Neck Exercises on Lung Function and Chest Expansion in Asthmatic Patients With Forward Head Posture
Enrollment
22 pts
Location
Pakistan
Sponsor
Foundation University Islamaba...
View Trial →
NCT07782996 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
Enrollment
370 pts
Location
United States, Japan
Sponsor
GlaxoSmithKline
View Trial →
NCT06159127
Recruiting
SMART@Home Feasibility Trial
Enrollment
25 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
View Trial →
NCT07536256
Recruiting
Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being
Enrollment
100 pts
Location
United States
Sponsor
Waianae Coast Comprehensive He...
View Trial →
NCT01225913 Phase 4
Recruiting
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Enrollment
50 pts
Location
United States
Sponsor
Gelb, Arthur F., M.D.
View Trial →
NCT06201494
Recruiting
Prospective Multicentre Study on Symptoms in First-onset Bronchial Asthma in Children and Adolescents
Enrollment
80 pts
Location
Czechia
Sponsor
Charles University, Czech Repu...
View Trial →
NCT04919265
Recruiting
Mother-Infant Cohort Study in Malaysia and China
Enrollment
200 pts
Location
Malaysia
Sponsor
Universiti Putra Malaysia
View Trial →
NCT07456033 Phase 3
Recruiting
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
Enrollment
456 pts
Location
United States, Unite...
Sponsor
GlaxoSmithKline
View Trial →
NCT03303586
Recruiting
Effects of Compression Stockings in Asthma Symptoms at Night
Enrollment
40 pts
Location
Canada
Sponsor
University Health Network, Tor...
View Trial →
NCT05272241
Recruiting
Registry of Asthma Characterization and Recruitment 3 (RACR3)
Enrollment
1,500 pts
Location
United States
Sponsor
National Institute of Allergy ...
View Trial →
NCT06681545
Recruiting
Exploring the Lived Experience of Young Adults With Severe Asthma
Enrollment
46 pts
Location
United Kingdom
Sponsor
Manchester University NHS Foun...
View Trial →

Related Conditions

asthma in children (3) dyspnea (2) eczema (2) wheezing (2) polycystic ovary syndrome (1) chronic obstructive pulmonary disease (1) healthy (1) effect of drug (1) respiratory tract infections (1) gastrointestinal infection (1) croup (1) allergy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology